BIOMAKERS logo

BIOMAKERS

Empowering Therapies with Precision Data

68 employees · est. 2014 · San Francisco, United States

VS
Probmet Therapeutics logo

Probmet Therapeutics

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients.

2 employees · est. 2022 · Denmark

BIOMAKERS is the older company (2014 vs 2022); BIOMAKERS is the larger of the two.

Side-by-Side Comparison

BIOMAKERS Probmet Therapeutics
Founded
2014 older 2022
Headquarters
San Francisco, United States Denmark
Employees
68 larger 2
Industry
Biopharma, Biotechnology, Health and Wellness Health Care, Health and Wellness
Funding Stage
Not tracked yet Convertible Note
Total Funding
Not tracked yet $500.00K
Funding Rounds
Not tracked yet 1
Services
Not tracked yet Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy
Target Customers
Not tracked yet Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies
Taxonomy
Precision Medicine, Genomic Analysis, Cancer Research, Rare Diseases, Tumor Biobank, Molecular Testing, Drug Development, Genomic Data Analysis, Pharmacogenetics, Hereditary Diseases, Oncology, AI For Cancer, Biopharmaceutical, Sequencing Labs Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals
Website
biomakers.net probmet.com
BIOMAKERS logo

About BIOMAKERS

BIOMAKERS is a global Precision Medicine Company focused on producing complex & advanced genomic data + RWE for cancer and rare diseases, aiming to extend the lifespan of cancer patients and revolutionize data-driven Drug Development in oncology worldwide. The company has developed a groundbreaking...

Probmet Therapeutics logo

About Probmet Therapeutics

Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission r...

We will tell you when either one moves

BounceWatch watches BIOMAKERS and Probmet Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BIOMAKERS and Probmet Therapeutics — by email.

Frequently Asked Questions

BIOMAKERS — Empowering Therapies with Precision Data. Probmet Therapeutics — An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BIOMAKERS has raised undisclosed funding while Probmet Therapeutics has raised $500.00K.
BIOMAKERS and Probmet Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BIOMAKERS with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BIOMAKERS on 11 Nov 2024, and Probmet Therapeutics on 14 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy